Svenska English

Unimedic signs distribution deal with Martindale pharma

Postat 2017/03/24

Several new products for commercialisation in the Nordics has been signed between Unimedic Pharma and Martindale Pharma

Espranor®, maybe the most promising of these products, provides a new innovative way of treating drug addiction. Already, there is a very positive and strong interest for the product in the Nordics, and “we believe Espranor will become the standard of care within this segment” says Anders Edvell, CEO.

The other products, Silocalm, Prenoxad and Morfin will also be available during 2017.

We are very happy with our already fruitful cooperation with Martindale, and to be able to further consolidate our cooperation with Martindale going forward, says Anders Edvell.